Technical420 Site Search

The Canadian medical cannabis industry continues to be a bright spot in the cannabis sector as its constituents are led by management teams that continue to execute on business initiatives and create value for shareholders.One the biggest developments in 2015 was the victory by Justin Trudeau and the Liberal Party…

Insys Therapeutics, Inc. (INSY) is up more than 3% in pre-market trading after the Nasdaq-trade cannabis company reported its financial results for the second quarter, which ended on June 30th.This report comes less than a month after Insys announced that the FDA approved Syndros, an orally administered liquid formulation of…

The state of the global economy has led to a number of the best investors and economists to predict a recession within the next 12 to 18 months.As market volatility continues to increase, investors and money managers will continue to exit the stock market as they look for new investment…

MassRoots, Inc. (MSRT), the “Facebook of the marijuana industry” filed its S-1 Registration Statement in an offering to up-list onto the Nasdaq Capital Market exchange.In the application, MassRoots stated that they plan to list on the exchange under the symbol MSRT. The company should hear back from the exchange within…

The termination of the $160 billion merger between Pfizer Inc. (PFE) and Allergan Plc (AGN) has been confirmed.The driving factor behind this decision stems from the rules issued by the United States Treasury Department which are focused on making tax inversion deals less profitable.Moving Addresses, Not AssetsPresident Obama said the…

MassRoots (MSRT) is one of the largest and most active technology platforms for cannabis consumers, businesses and activists with over 775,000 users. After MSRT completed a $1.4+ million capital raise late last week, we believe the company now meets all Nasdaq listing requirement and we expect to see an S-1 filed…

Before recreational marijuana became legal in Colorado on January 1, 2014, there were less than 50 publicly traded cannabis companies; today there are over 350. Most of these companies trade on the over-the-counter (OTC) exchange which is comprised of startups, defunct public shell companies, scams, and a select number of…

GW Pharmaceuticals plc (GWPH) is a pharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform. GWPH commercialized the world's first plant-derived cannabinoid prescription drug, Sativex, which is approved for the treatment of spasticity due to multiple sclerosis in 27 countries outside the United…

The National Cancer Institute (NCI) updated its website to include various studies revealing how cannabis may inhibit tumor growth by killing cells, blocking cell growth, and blocking the development of blood vessels that tumors need to grow. The institute released the following statement after updating its website:“A laboratory study of…

What happens when you combine a hot biotech initial public offering (IPO) market with a NASDAQ traded cannabis stock focused on treatments that have a multi-billion dollar Total Addressable Market (TAM)?  Just take a look at Zynerba Pharmaceuticals (ZYNE).On August 5th, ZYNE conducted its IPO on the NASDAQ exchange and…